2018
DOI: 10.1136/gutjnl-2018-316581
|View full text |Cite
|
Sign up to set email alerts
|

Severe bleeding is a rare event in patients receiving lumen-apposing metal stents for the drainage of pancreatic fluid collections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
9
0
1

Year Published

2019
2019
2020
2020

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 6 publications
1
9
0
1
Order By: Relevance
“…However, 75% (3/4) bleeding cases in LAMS of our study was observed at about 1 week after procedure, indicating that early bleeding might be more frequent than expected. To confirm this finding, studies reporting the time and outcomes of bleeding were systemically retrieved in Table S1 and summarized in Table . Generally, bleeding was reported in 34 patients from eight studies during the first 3 weeks, which was reported in only 16 patients from six studies 3 weeks after intervention.…”
Section: Discussionmentioning
confidence: 90%
“…However, 75% (3/4) bleeding cases in LAMS of our study was observed at about 1 week after procedure, indicating that early bleeding might be more frequent than expected. To confirm this finding, studies reporting the time and outcomes of bleeding were systemically retrieved in Table S1 and summarized in Table . Generally, bleeding was reported in 34 patients from eight studies during the first 3 weeks, which was reported in only 16 patients from six studies 3 weeks after intervention.…”
Section: Discussionmentioning
confidence: 90%
“…Currently, endoscopic drainage has become the first-line approach for treating symptomatic WON, comparing favorably with minimally invasive surgical intervention[ 20 - 22 ]. Although traditional endoscopic drainage involves stenting of some sort to ensure a patent fistula and effective drainage, the inefficiency of plastic stents[ 10 , 11 ], the complications (especially delayed bleeding) that may develop[ 13 , 14 , 17 ], and cost[ 13 ] of LAMS devices are problematic. Liu et al [ 19 ] reported the emergency use of endoscopic gastric mural fenestration under EUS and CT guidance to treat a recurrent pancreatic pseudocyst.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, various studies assessing LAMS have published disparate safety findings, with overall adverse event (AE) rates ranging from 0 % to 50 % 9 10 11 12 . Specific adverse events (AEs) such as bleeding also have widely varying reported rates, ranging from 0 % to 25 %, with some studies (including those with small sample size) suggesting a higher rate of bleeding with LAMS compared to DPPS 9 13 14 15 16 . In addition, the relatively large variations in reported complication rates may be partially attributable to their different definitions 17 .…”
Section: Introductionmentioning
confidence: 99%